Medtronic plc (NYSE:MDT) is included among the Early Retirement Portfolio: Top 15 Stocks to Buy.
On April 13, Mizuho lowered the firm’s price recommendation on Medtronic plc (NYSE:MDT) to $120 from $125. It kept an Outperform rating on the shares. The firm made the adjustment as it updated estimates and price targets across several names in its medical devices and diagnostics coverage ahead of Q1 earnings.
On April 7, Citi analyst Joanne Wuensch also lowered the price target on Medtronic to $110 from $117, while maintaining a Buy rating. The changes were part of a broader Q1 preview for the medical technology group. The analyst said the “walls of worry are high” heading into earnings, with the sector seeing significant multiple compression, according to a research note. Citi also removed iRhythm and Medtronic as top picks, naming Edwards Lifesciences and Intuitive Surgical as its new top choices.
Medtronic plc (NYSE:MDT) is based in Ireland and provides healthcare technology solutions. Its products are organized across four main segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes.
While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 14 Value Stocks with Highest Dividends and 15 Cash-Rich Dividend Stocks to Invest In Right Now
Disclosure: None. Follow Insider Monkey on Google News.
